Benchmark Downgrades Bio-Techne to Hold
Benchmark analyst Robert Wasserman downgrades Bio-Techne (NASDAQ: TECH ) from Buy to Hold.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.